Tampere University
Clinical trials sponsored by Tampere University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Virtual heart model aims to predict and prevent HCM complications Results expected Dec 2026 (estimated)
- Can a phone app help kids move better? school trial aims to find out Results expected Jan 2027 (estimated)
- Is waiting safe for AFib? new study tests delayed treatment Results expected Jun 2027 (estimated)
- Can exercise help older caregivers? new study aims to find out Results expected Aug 2027 (estimated)
-
Can a phone app help kids move better? school trial aims to find out
Disease control By invitation onlyThis study tests whether a mobile app called Geego Kids can improve motor skills in first-grade children. Over 12 weeks, teachers lead short movement breaks in class, and children do weekly homework activities with family support. The goal is to see if the app helps kids become m…
Sponsor: Tampere University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Which treatment works best for Dupuytren's? major trial aims to find out
Disease control OngoingThis study compares three treatments for Dupuytren's contracture, a hand condition that causes fingers to bend inward. The treatments are needle fasciotomy (a quick in-office procedure), collagenase injection (a drug that breaks up the tight cord), and surgery (limited fasciectom…
Phase 4 • Sponsor: Tampere University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Home breathing aid for ALS: just as good as hospital?
Symptom relief OngoingThis study looks at whether starting noninvasive ventilation (a breathing mask) at home works as well as starting it in the hospital for people with ALS who have chronic breathing problems. Researchers will track how many hours patients use the device and whether their blood carb…
Sponsor: Tampere University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Virtual heart model aims to predict and prevent HCM complications
Knowledge-focused OngoingThis study is developing a digital twin—a virtual model of the heart and blood vessels—to better understand and manage hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. Researchers will gather detailed health data from 2500 people with HCM or the gen…
Sponsor: Tampere University • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC